Noom CEO Proposes 'Habit Window' Framework to Fix GLP-1 Dropout Rates
Toronto – September 15, 2026 -- A new viewpoint paper published in the Journal of Medical Internet Research argues that GLP-1 weight-loss drugs fail long-term without paired digital behavioral coaching, citing high patient dropout and rapid weight regain as persistent industry problems. The paper, authored by Noom CEO Geoff Cook, introduces a "habit window hypothesis" and calls for a formal research agenda to test whether digital health apps can extend the durability of pharmacological weight loss.